News Cradle Genomics raises $17m for prenatal genetic testing R&D Prenatal testing firm Cradle Genomics has raised $17 million in an early funding round led by the investment arm of the genetic testing firm Illumina.
News BioMarin ends year with $4.8bn play for Amicus BioMarin takes a leap towards its $4bn revenue target with a $4.8bn deal to acquire Amicus, which has two rare disease therapies on the market.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.